CLOV

Clover Health Investments Co Cross-source read$4.82 2.34%
Health CareCUSIP 18914F103· EOD Sep 11, 2026

Among active 13F managers last quarter, 11 opened and 20 added, while 11 reduced; the largest holder to move was Citadel Advisors LLC (+15%). Over the last 180 days, 8 insiders sold and none bought, a net -$4.6M in open-market trades.

Tracked 13F holders
202
122 in Q2 2026 filings
13F value (tracked)
$560.1M
Smart-money readMixed
Net sellingNet buying
Funds · active managers, latest 13F
31 adding · 11 trimming
Insiders · Form 4 open-market, 180d
0 buying · 8 selling · -$4.6M
US House · STOCK Act, 180d
0 buying · 0 selling

The legs disagree, or only one of them leans.

Price & smart-money activity

$4.82 2.34%5Y -41.9%
$0.02$2.24$4.47$6.69$8.9120212022202320242025202613202415222222220211721211425192131613201621520413233013342233530738334437373453824841352420
Hover for who · click for detailEnd-of-day closing prices52w $1.70 – $5.41

Who owns CLOV?

202 tracked 13F filers · ranked by shares held

202 tracked 13F filers disclose a position in CLOV as of the latest SEC 13F filings, a combined $560.1M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1BlackRock, Inc.35.1M
$184.0M
+10%
Added · +3.3M sh
Q2 2026
2Vanguard Capital Management LLC18.0M
$94.5M
+6.2%
Added · +1.1M sh
Q2 2026
3Geode Capital Management, LLC10.8M
$56.8M
+7.9%
Added · +791K sh
Q2 2026
4State Street Corp10.2M
$53.3M
+6.5%
Added · +620K sh
Q2 2026
5Charles Schwab Investment Management Inc5.3M
$9.3M
+13%
Added · +610K sh
Q1 2026
6Vanguard Portfolio Management LLC4.5M
$23.4M
+21%
Added · +774K sh
Q2 2026
7PNC Financial Services Group, Inc.3.8M
$6.6M
~0%
Added · +183 sh
Q1 2026
8Dimensional Fund Advisors LP3.4M
$6.0M
−6.0%
Reduced · −216K sh
Q1 2026
9Renaissance Technologies LLC3.4M
$6.0M
−24%
Reduced · −1.1M sh
Q1 2026
10Northern Trust Corp3.3M
$5.8M
+4.0%
Added · +128K sh
Q1 2026
11Vanguard Fiduciary Trust Co2.9M
$15.3M
+4.0%
Added · +114K sh
Q2 2026
12Morgan Stanley2.2M
$3.8M
−16%
Reduced · −413K sh
Q1 2026
13Goldman Sachs Group Inc2.2M
$3.8M
+22%
Added · +384K sh
Q1 2026
14Citadel Advisors LLC2.2M
$11.3M
+15%
Added · +285K sh
Q2 2026
15UBS Group AG1.8M
$3.1M
+34%
Added · +452K sh
Q1 2026
16GMT Capital Corp1.3M
$2.3M
New
+1.3M sh
Q1 2026
17Caxton Associates LLP1.2M
$6.4M
New
+1.2M sh
Q2 2026
18Millennium Management LLC1.2M
$2.1M
New
+1.2M sh
Q1 2026
19Bank of New York Mellon Corp1.1M
$2.0M
−3.0%
Reduced · −35K sh
Q1 2026
20Point72 Asset Management, L.P.1.1M
$5.6M
+113%
Added · +567K sh
Q2 2026
21Jane Street Group, LLC1.0M
$1.8M
+78%
Added · +455K sh
Q1 2026
22Nuveen, LLC936K
$1.6M
+5.9%
Added · +52K sh
Q1 2026
23Susquehanna International Group, LLP899K
$1.6M
−61%
Reduced · −1.4M sh
Q1 2026
24Swiss National Bank828K
$1.5M
Held
Q1 2026
25Group One Trading LLC747K
$3.9M
+27%
Added · +160K sh
Q2 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is CLOV being bought or sold by institutions?

Last quarter, 11 funds opened a new position in CLOV and 20 added to an existing one, while 11 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
11
funds took a first position
Added
20
added to an existing position
Reduced
11
reduced, still holding
Biggest moves · ranked by size of the change, positions above a floor

Funds that own CLOV also own

CompanyCo-held byTheir position there
Microsoft CorpMSFT101 funds$161.6B
Amazon.com IncAMZN100 funds$125.0B
Nvidia CorpNVDA99 funds$260.9B
Alphabet Inc-CL AGOOGL99 funds$109.4B
Meta Platforms Inc-Class AMETA97 funds$70.1B
Advanced Micro DevicesAMD96 funds$40.0B
Micron Technology IncMU96 funds$38.9B
JPMorgan Chase & CoJPM96 funds$38.0B
Chevron CorpCVX96 funds$17.2B
Broadcom IncAVGO95 funds$109.1B
Visa Inc-Class A SharesV95 funds$41.2B
Apple IncAAPL94 funds$184.3B

Ranked by how many of CLOV's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in CLOV.

Insider activity (Form 4)

Full insider page →
Sells · 180d
$4.6M
8 insiders
Net · 180d
-$4.6M
20 open-market transactions
DateInsiderRoleActionSharesValue
Aug 17, 2026Thornton Joseph ClayInterim CFOSell (S)18K$78K
Aug 10, 2026Toy AndrewChief Executive Officer, DirectorSell (S)88K$408K
Jul 20, 2026Soares KarenChief Legal OfficerSell (S)52K$233K
Jul 17, 2026Reynoso Jamie L.CEO, Medicare AdvantageSell (S)5K$22K
Jul 15, 2026Soares KarenChief Legal OfficerSell (S)11K$49K
Jul 15, 2026Wai ConradCEO, Counterpart HealthSell (S)24K$113K
Jul 15, 2026Toy AndrewChief Executive Officer, DirectorSell (S)63K$293K
Jul 15, 2026Reynoso Jamie L.CEO, Medicare AdvantageSell (S)13K$61K
Jul 15, 2026Thornton Joseph ClayInterim CFOSell (S)5K$22K
Jul 8, 2026Reynoso Jamie L.CEO, Medicare AdvantageSell (S)2K$11K
Jul 6, 2026Reynoso Jamie L.CEO, Medicare AdvantageSell (S)6K$33K
Jul 1, 2026Toy AndrewChief Executive Officer, DirectorSell (S)313K$1.7M

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
4428
Insiders
Form 4 open-market
08-$4.6M
US House
STOCK Act trades
00$0
Sector rotation
CLOV is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

122 tracked filers in Q2 2026 filingsstill filing
096191Q3 2024Q1 2025Q3 2025Q1 2026Q2 2026
tracked filers holding their reported valueQ2 2026 filings so far: $488.6M
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Recent filings

15 most recent

Keep exploring

Connected entities for CLOV

Browse more

Build

Ask your agent what changed in CLOV

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/CLOV/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for CLOV.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for CLOV. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.